Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies. Find out more about cookies.

Click here to dismiss this banner

YOU MIGHT BE INTERESTED IN

  1. Point of Care Coagulation Testing: World Market 2013-2023

    Point of Care Coagulation Testing: World Market 2013-2023

    In 2011, the global point of care diagnostics market was worth $13.8bn, with high single-digit growth from the year before. Despite being a vast and mature market, there are number of sectors likely to experience fast growth during the next 10 years. Much of this growth is linked to the prevalence of a number of diseases worldwide, as well as an aging population. The preference for at home testing and its convenience will continue to drive the point of care diagnostics market.

    ...more details

PHARMA REPORT

rss_Pharma.jpg...see all
Self Monitoring Blood Glucose Devices: World Market Outlook 2012-2022

Self Monitoring Blood Glucose Devices: World Market Outlook 2012-2022

  • Publication date: 06/11/2012
  • Number of Pages: 120
  1. Report Details
  2. Table of Contents
  3. Companies Listed

Report Details

Medical devices are playing an increasingly important role in diabetes. Products such as blood glucose monitors and insulin pumps have now become the cornerstone for management of blood glucose levels. Self monitoring blood glucose (SMBG) monitors are gaining popularity with increasing number of patients getting more aware of the need to better manage their diabetes and going for regular home monitoring of their blood glucose levels. The ease of use of SMBG devices has been a driving factor for their adoption.

The market has continuously evolved with respect to technology for SMBG devices. There is a growing interest in a new innovative technology, known as continuous glucose monitoring, which can offer regular blood glucose measurements (typically every few minutes). This is particularly useful as it provides a greater insight into glucose levels throughout the day through the implantation of a small sensor under the skin. It is hoped that in the future these implantable sensors may be able to automatically adjust insulin infusion rates delivered by insulin pumps.

Self Monitoring Blood Glucose Devices: World Market Outlook 2012-2022 analyses the top four companies involved in the diabetes monitoring devices market. This report also provides sales forecasts, market share analyses, discussions of technological developments and analyses of commercial drivers and restraints, including SWOT analysis of the overall diabetes monitoring device market. There are over 90 tables and figures included. The result is comprehensive profile on the leading companies operating in the SMBG devices market with detailed analyses and informed opinion to benefit your work. Visiongain has determined that the value of the global self monitoring blood glucose devices market will reach $27.42bn in 2022.

What makes this report unique?

Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national markets forecasts from 2012-2022 - all highlighting key business opportunities.

Why you should buy Self Monitoring Blood Glucose Devices: World Market Outlook 2012-2022

• 107 pages of comprehensive analysis
• 1 Exclusive Visiongain interviews with experts from-
- Echo Therapeutics
• 94 tables, charts, and graphs
• Global diabetes monitoring devices market forecast between 2012-2022
• 3 diabetes monitoring devices submarket forecasts from 2012-2022
- Glucose Test Strips
- Glucose Meters
- Continuous Glucose Monitoring (CGM)
• A SWOT analysis
• Several leading companies identified and 4 profiled -
- Roche
- Abbott Diagnostics
- LifeScan (Johnson & Johnson)
- Bayer Healthcare

You can order this report today

Gain an understanding of the overall SMBG devices market and the leading companies operating in this market by ordering Self Monitoring Blood Glucose Devices: World Market Outlook 2012-2022.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6  

Table of Contents

1. Executive Summary
1.1 Sector Highlights
1.2 Aims, Scope and Format of the Report
1.3 Chapter Outline
1.4 Research and Analysis Methods
1.5 Glossary of Terms Related to the Report

2. Introduction To Diabetes And Monitoring Devices
2.1 What is Diabetes?
2.1.1 Classifying Diabetes
2.1.2 Symptoms And Long-Term Complications
2.1.3 Treatment
2.1.4 Diagnosis
2.2 Diabetes Monitoring
2.2.1 Glucose Levels
2.2.1.1 Reagent Strips And Glucose Meters
2.2.1.2 Urine Testing
2.2.1.3 Haemoglobin A1c Testing
2.2.2 Blood Pressure
2.2.3 Blood Cholesterol
2.2.4 Eye Tests
3. The Global Self Monitoring Blood Glucose Devices Market, 2011-2022
3.1 The Global Diabetes Care Devices Market, 2011
3.2 SMBG Devices Market, 2011
3.3 Global SMBG Devices Market Forecast, 2012-2022

4. Glucose Test Strips Market, 2011-2022
4.1 Glucose Test Strips
4.2 Glucose Test Strips: Market Forecast, 2012-2022
4.2.1 Glucose Test Strips: Industry Trends, 2012-2022
4.3 Companies and Products
4.3.1 Abbott Diabetes Care
4.3.2 Bayer Healthcare
4.3.3 Roche
4.3.4 LifeScan
4.3.5 Nipro Diagnostics

5. Glucose Meters Market, 2011-2022
5.1 Glucose Meters
5.1.1 How It Works
5.2 Marketed Glucose Meters
5.3 Glucose Meters: Market Forecast, 2012-2022
5.4 Glucose Meters: Industry Trends, 2012-2022
5.4.1 Technology Advancements
5.4.2 Growing Significance of Emerging Markets
5.4.3 Emergence of CGMs

6. Continuous Glucose Monitoring Market, 2011-2022
6.1 Continuous Glucose Monitoring (CGM)
6.2 Continuous Glucose Monitoring Market, 2011
6.3 Continuous Glucose Monitoring (CGM) Systems vs. Fingertip Testing
6.3.1 The CGM Pipeline
6.4 Continuous Glucose Monitoring: Market Forecast, 2012-2022
6.5 Continuous Glucose Monitoring: Industry Trends, 2012-2022
6.5.1 Improved Glucose Control
6.5.2 The US is the Largest Market for CGMs
6.5.3 Challenges to Growth of CGMs

7. Leading Companies In The SMBG Devices Market, 2011
7.1 Market Showing Signs of Recovery
7.2 SMBG Devices Market: Breakdown By Company, 2011
7.3 Roche
7.3.1 Sales and Recent Performance Analysis, 2011
7.3.1.1 Roche Diagnostics
7.3.2 Roche Diagnostics Geographic Sales
7.3.3 Marketed Glucose Meters
7.4 Abbott Laboratories
7.4.1 Sales and Recent Performance Analysis, 2011
7.4.2 Abbott Geographic Sales
7.4.3 Marketed Glucose Meters
7.5 LifeScan
7.5.1 Sales and Recent Performance Analysis, 2011
7.5.1.1 Medical Devices And Diagnostics (MD&D)
7.5.2 J&J Geographic Sales
7.5.3 Marketed Glucose Meters
7.6 Bayer Group
7.6.1 Sales and Recent Performance Analysis, 2011
7.6.1.1 Bayer Healthcare
7.6.1.1.1 Consumer Health
7.6.2 Bayer Healthcare Geographic Sales
7.6.3 Marketed Glucose Meters
7.7 Other Companies

8. Leading National SMBG Devices Markets, 2011-2022
8.1 Regional Breakdown of The Global SMBG Devices Market, 2011
8.2 The Global SMBG Devices Market: Regional Forecast, 2012-2022
8.3 The US Market
8.4 The European Market
8.4.1 Germany
8.4.2 France
8.4.3 Italy
8.4.4 Spain
8.4.5 UK
8.5 The Japanese Market
8.6 The Chinese Market
8.7 The Indian Market

9. SWOT Analysis of the SMBG Devices Market, 2012
9.1 SMBG Devices: Industry Trends
9.2 Strengths
9.2.1 Effective Disease Management
9.2.2 Technological Advancements
9.2.3 Patient Demographics
9.3 Weaknesses
9.3.1 Regulatory Board Approvals
9.3.2 Benefits Vs. Costs
9.3.3 Reimbursement Issues
9.4 Opportunities
9.4.1 Globalisation
9.4.2 Continuous Glucose Monitoring (CGM)
9.4.3 Mobile Applications
9.5 Threats
9.5.1 "Burnout"
9.5.2 Lack of Innovation
9.5.3 Decreasing Investments

10. Opinions from Our Industry Survey
10.1 Interview with Echo Therapeutics
10.1.1 The Growth of Continuous Glucose Monitoring
10.1.2 The Symphony® tCGM device

11. Conclusions
11.1 Overview
11.2 Glucose Test Strips will Remain the Largest Segment
11.3 Prominent Companies in the Market
11.4 World Market Forecasts
11.5 Future Outlook and Concluding Remarks

Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form

List of Tables
Table 3.1 The Global Diabetes Care Devices Market: Net Sales ($bn) and Market Shares (%), By Sector, 2011
Table 3.2 SMBG Devices Market: Net Sales ($bn) and Market Shares (%), By Product, 2011
Table 3.3 Global SMBG Devices Market Forecast ($bn), By Technology, 2011-2016
Table 3.4 Global SMBG Devices Market Forecast ($bn), By Technology, 2016-2022
Table 4.1 Glucose Test Strips: Market Forecast ($bn), 2011-2016
Table 4.2 Glucose Test Strips: Market Forecast ($bn), 2016-2022
Table 5.1 Marketed Glucose Meters, 2012
Table 5.2 Glucose Meters: Market Forecast ($bn), 2011-2016
Table 5.3 Glucose Meters: Market Forecast ($bn), 2016-2022
Table 6.1 CGM Market: Net Sales ($m) and Market Shares (%) By Product, 2011
Table 6.2 Advantages of CGMs over Fingerstick Testing Systems, 2011
Table 6.3 Marketed CGMs, 2012
Table 6.4 CGM Pipeline, 2012
Table 6.5 CGM Devices: Market Forecast ($bn), 2011-2016
Table 6.6 CGM Devices: Market Forecast ($bn), 2016-2022
Table 7.1 Leading Companies in the SMBG Devices Market: Net Sales ($bn) and Market Shares (%), 2011
Table 7.2 Roche: Net Sales ($bn) & Market Shares (%) By Sector, 2011
Table 7.3 Roche Diagnostics: Net Sales ($bn) & Market Shares (%) By Product Line, 2011
Table 7.4 Roche Diagnostics: Net Sales ($bn) and Market Shares (%) By Region, 2011
Table 7.5 Roche Diagnostics Glucose Meters, 2012
Table 7.6 Abbott: Net Sales ($bn) & Market Shares (%) By Sector, 2011
Table 7.7 Abbott: Net Sales ($bn) and Market Shares (%) By Region, 2011
Table 7.8 Johnson & Johnson: Net Sales ($bn) & Market Shares (%) By Segment, 2011
Table 7.9 J&J Medical Devices & Diagnostics: Net Sales ($bn) & Market Shares (%) By Franchise, 2011
Table 7.10 J&J Medical Devices & Diagnostics: Net Sales ($bn) & Market Shares (%) By Region, 2011
Table 7.11 LifeScan Glucose Meters, 2012
Table 7.12 Bayer Group: Net Sales ($bn) & Market Shares (%) By Segment, 2011
Table 7.13 Bayer Healthcare: Net Sales ($bn) & Market Shares (%) By Segment, 2011
Table 7.14 Bayer Consumer Health: Net Sales ($bn) & Market Shares (%) By Segment, 2011
Table 7.15 Bayer Healthcare: Net Sales ($bn) & Market Shares (%) By Region, 2011
Table 7.16 Bayer Healthcare Glucose Meters, 2012
Table 7.17 Other Companies Operating in The Self Monitoring Blood Glucose Devices Market, 2012
Table 8.1 SMBG Devices Market: Sales ($bn) and Market Shares (%) By Country/Region, 2011
Table 8.2 SMBG Devices Market: Market Forecast ($bn) By Country/Region, 2011-2022
Table 8.3 The Leading European SMBG Devices Markets: Market Value ($bn), European Market Shares (%) and Global Market Shares (%) By Region, 2011
Table 8.4 The European SMBG Devices Market Forecast ($bn) By Region, 2011-2022
Table 9.1 SWOT Analysis of the Global SMBG Devices Market, 2012-2022
Table 11.1 SMBG Devices Market Forecast ($bn) By Product, 2011, 2016, 2018 and 2022

List of Figures
Figure 3.1 The Global Diabetes Care Devices Market: Net Sales ($bn), By Sector, 2011
Figure 3.2 The Global Diabetes Care Devices Market: Market Shares (%), By Sector, 2011
Figure 3.3 SMBG Devices Market: Net Sales ($bn), By Product, 2011
Figure 3.4 SMBG Devices Market: Market Shares (%), By Product, 2011
Figure 3.5 Global SMBG Devices Market Forecast ($bn), By Technology, 2011-2016
Figure 3.6 Global SMBG Devices Market Forecast ($bn), By Technology, 2016-2022
Figure 4.1 Glucose Test Strips: Market Forecast ($bn), 2011-2016
Figure 4.2 Glucose Test Strips: Market Forecast ($bn), 2016-2022
Figure 5.1 Glucose Meters: Market Forecast ($bn), 2011-2016
Figure 5.2 Glucose Meters: Market Forecast ($bn), 2016-2022
Figure 6.1 CGM Market: Net Sales ($m) By Product, 2011
Figure 6.2 CGM Market: Market Shares (%) By Product, 2011
Figure 6.3 CGM Devices: Market Forecast ($bn), 2011-2016
Figure 6.4 CGM Devices: Market Forecast ($bn), 2016-2022
Figure 7.1 Leading Companies in the SMBG Devices Market: Net Sales ($bn), 2011
Figure 7.2 Leading Companies in the SMBG Devices Market: Market Shares (%), 2011
Figure 7.3 Roche: Net Sales ($bn) By Sector, 2011
Figure 7.4 Roche: Market Shares (%) By Sector, 2011
Figure 7.5 Roche Diagnostics: Net Sales ($bn) By Product Line, 2011
Figure 7.6 Roche Diagnostics: Market Shares (%) By Product Line, 2011
Figure 7.7 Roche Diagnostics: Net Sales ($bn) By Region, 2011
Figure 7.8 Roche Diagnostics: Market Shares (%) By Region, 2011
Figure 7.9 Abbott: Net Sales ($bn) By Sector, 2011
Figure 7.10 Abbott: Market Shares (%) By Sector, 2011
Figure 7.11 Abbott: Net Sales ($bn) By Region, 2011
Figure 7.12 Abbott: Market Shares (%) By Region, 2011
Figure 7.13 Johnson & Johnson: Net Sales ($bn) By Segment, 2011
Figure 7.14 Johnson & Johnson: Market Shares (%) By Segment, 2011
Figure 7.15 J&J Medical Devices & Diagnostics: Net Sales ($bn) By Franchise, 2011
Figure 7.16 J&J Medical Devices & Diagnostics: Market Shares (%) By Franchise, 2011
Figure 7.17 J&J Medical Devices & Diagnostics: Net Sales ($bn) By Region, 2011
Figure 7.18 J&J Medical Devices & Diagnostics: Market Shares (%) By Region, 2011
Figure 7.19 Bayer Group: Net Sales ($bn) By Segment, 2011
Figure 7.20 Bayer Group: Market Shares (%) By Segment, 2011
Figure 7.21 Bayer Healthcare: Net Sales ($bn) Segment, 2011
Figure 7.22 Bayer Healthcare: Market Shares (%) Segment, 2011
Figure 7.23 Bayer Consumer Health: Net Sales ($bn) By Segment, 2011
Figure 7.24 Bayer Consumer Health: Market Share (%) By Segment, 2011
Figure 7.25 Bayer Healthcare: Net Sales ($bn) By Region, 2011
Figure 7.26 Bayer Healthcare: Market Shares (%) By Region, 2011
Figure 8.1 SMBG Devices Market: Sales ($bn) By Country, 2011
Figure 8.2 SMBG Devices Market: Market Shares (%) By Country, 2011
Figure 8.3 The US SMBG Devices Market Forecast ($bn), 2011-2022
Figure 8.4 The European SMBG Devices Market: Net Sales ($bn) By Region, 2011
Figure 8.5 The European SMBG Devices Market: Market Shares (%) By Region, 2011
Figure 8.6 The European SMBG Devices Market Forecast ($bn), 2011-2022
Figure 8.7 The German SMBG Devices Market Forecast ($bn), 2011-2022
Figure 8.8 The French SMBG Devices Market Forecast ($bn), 2011-2022
Figure 8.9 The Italian SMBG Devices Market Forecast ($bn), 2011-2022
Figure 8.10 The Spanish SMBG Devices Market Forecast ($bn), 2011-2022
Figure 8.11 The UK SMBG Devices Market Forecast ($bn), 2011-2022
Figure 8.12 The Japanese SMBG Devices Market Forecast ($bn), 2011-2022
Figure 8.13 The Chinese SMBG Devices Market Forecast ($bn), 2011-2022
Figure 8.14 The Indian SMBG Devices Market Forecast ($bn), 2011-2022
Figure 11.1 Projected SMBG Devices Market Growth for 2016, 2018 and 2022, By Product
Figure 11.2 Projected Total SMBG Devices Market Size ($bn) In 2011, 2016, 2018 and 2022 

Companies Listed

A. Menarini
Abbott Laboratories
AgaMatrix
AIMEDICS
All Medicus
Alere
ArKal Medical
Arkray
Bayer Healthcare
BioRad Laboratories
Biorasis
Braun Melsungen
C8 MediSensors
DePuy
DexCom
Bionime
Echo Therapeutics
EyeSense
GluMetrics
GluSense Medical
Hainice Medical
Johnson & Johnson
LifeScan
Medtronic
Mellitor
Nipro Diagnostics
Nova Biomedical
Piramal Enterprises
Positive ID
Roche
Sanofi Aventis
Sensors for Medicine and Science
Siemens Healthcare
Ultradian Diagnostics
Wockhardt

Government Agencies and Other Organisations Mentioned in This Report
Food and Drug Administration (FDA)
Ministry of Health (MoH), Germany
Pharmaceuticals and Medical Devices Agency (PMDA)
World Health Organization (WHO)
American Association of Clinical Endocrinologists (AACE)
National Venture Capital Association 

 

You have successfully subscribed. Thank you.

An internal error has occurred. Please try again later.

close